how InvestingPro’s Fair Value spotted Hagerty’s 66% upside

Hagerty (NYSE: HGTY) rose 66.49% from $9.19 in March 2025 to $15.30 by October 2026, exceeding InvestingPro’s initial fair-value estimate of $13.91 and nearing its 52-week high of $15.53. Over the period, revenue increased 14% to $1.42 billion, EBITDA rose 55.5% to $228.1 million, and EPS climbed 57.4% to $0.16; the article also reports repeated earnings beats and guidance increases.

Analysis

The investable signal is not that a retrospective valuation model once identified HGTY; it is whether recent earnings improvement reflects durable underwriting economics or a favorable comparison period. For a specialty insurer and membership business, revenue growth alone is insufficient: retention, renewal pricing, claims severity, loss ratio, and the mix of insurance versus membership/other revenue determine whether EBITDA gains persist. The article provides no detail on these drivers, and its promotional framing is not independent evidence that the valuation method has repeatable alpha.

Near term, being close to a recent high after a strong run raises the bar for further upside: another guidance increase may be needed to sustain the multiple, while any miss could prompt profit-taking. Over 1–3 months, monitor the next results and guidance for continued margin improvement alongside policy growth and claims trends. Over 6–18 months, niche distribution and enthusiast engagement could support differentiation, but established insurers and specialty-car providers can constrain pricing; worsening repair costs or claims inflation could also erode underwriting gains. The thesis weakens if earnings growth stalls, guidance is cut, or loss metrics deteriorate. No valuation inputs in the article support a fresh fair-value estimate.

Key Decisions for Investors

• Do not chase HGTY solely on the retrospective Fair Value success story. Treat the article as promotional; it does not establish that the stock is undervalued today.
• Keep HGTY on an earnings-confirmation watchlist. Before adding exposure, verify comparable-period revenue and EBITDA, insurance-versus-other revenue mix, retention, renewal pricing, and loss-ratio trends from filings and earnings materials.
• For existing exposure, consider trimming into strength rather than adding near the recent high unless upcoming results confirm continued earnings growth without deterioration in claims performance.
• Falsifiers: a guidance reduction, slowing policy or revenue growth, or worsening loss metrics would challenge the durability thesis; sustained margin expansion with stable claims experience would support revisiting the position.